Ectropion and eyelid retraction after procedures

The lower eyelid looks like simple territory: little fat, thin skin, a muscle around it. In practice, it is an area of delicate balance between tension, support and volume. When a procedure near the orbit changes that balance, the eyelid edge can drop (retraction) or turn outward (ectropion), and the eye starts showing more sclera than normal.

This page brings together, at a review level, the mechanisms, warning signs and the logic of management and prevention. Technique details and treatment decisions rest with the qualified professional, according to the package insert and the rules of their professional council, and with the ophthalmologist when indicated.

What is what?

The first two can be subtle at first. A patient with mild retraction only notices a "more open" or more tired look, without symptoms. When it progresses to ectropion, burning, dry eye and running tears appear.

Why does this happen after a procedure?

Some described pathways, which add up in many cases:

• Traction from swelling or volume. Filler near the orbital rim can increase pressure in the tissue and make the eyelid "pulled" downward, especially when support is loose.
• Fibrosis and scarring. An inflammatory reaction, nodule or scar after previous intervention reduces tissue mobility and pulls.
• Loss of orbicularis muscle tone. Botulinum toxin can weaken the orbicularis oculi in the lower eyelid. In someone who already has little support, the edge drops.
• Toxin spread. Depending on the amount and dispersion, the effect can reach neighboring muscles and reduce tension.
• Previous eyelid surgery. In operated patients, the posterior lamella of the eyelid has less reserve, and any additional volume may be poorly tolerated. See blepharoplasty.
• Laxity of the lateral canthal tendon. When support at the outer corner is loose, any load on the eyelid tends to lower the edge.

How do you identify higher-risk patients?

Assessment before the procedure is the main prevention. Some findings call for extra caution.

In someone with the findings above, it is reasonable to consider whether the procedure is indicated, whether there is a more conservative alternative or whether the patient should be assessed by an ophthalmologist first. The anatomy is in periorbital anatomy for injectables and the assessment of the under-eye area is in under-eye circles: types and assessment.

How do you recognize it after the procedure?

Follow-up should include observing the eyelid with the patient seated, looking straight ahead, and also looking upward. Compare both eyes and compare with the photo from the day of assessment.

• Early signs: visible sclera, a more "rounded" look, eyelid not following the movement of the eye.
• Warning symptoms: burning, dry eye, tearing, a gritty sensation, redness, difficulty closing the eye at night.
• Signs that call for urgency: severe pain, visual change, double vision, an eye that does not close or corneal injury.

Timeline and management at a review level

Progression depends on the mechanism. The path below is general reasoning, and each case requires individual examination and decision.

While the condition lasts, the patient may need eye lubrication and guidance on protecting the cornea during sleep. The ophthalmologist or the physician who follows the patient decides what to use, not a generic recommendation. Hyaluronidase should be available whenever hyaluronic acid is injected, as hyaluronidase in the office reminds us.

When to refer

Always document the progression with standardized clinical photography, the patient's account and the actions taken, in the patient record. Candid communication with the patient about the risk before the procedure, in the informed consent form, avoids surprises later.

Questions patients often ask

"My eye looks bigger after the procedure. Is that normal?"

A slight change in the shape of the look can occur with swelling and with adjustment of the volume, and it often improves. What is not expected is sclera newly showing, an irritated eye or difficulty closing. In those cases, the follow-up visit should be brought forward and management defined based on examination, not on reassurance.

"Will it go back to normal?"

It depends on the cause. When the factor is toxin or swelling, the trend is to improve with time. When it is fibrosis, poorly placed volume or previous surgery, intervention may be needed. It is prudent to avoid promising complete recovery before diagnosis.

"Can I have another procedure in the area to correct it?"

Before adding anything to the area, it is worth understanding the mechanism. Treating a pulled eyelid with more volume or more toxin can make things worse. In many cases the first step is to reduce the load, not add to it.

What to record in the patient file

Document the distance between the eyelid margin and the iris limbus when possible, the presence of sclera, the eye symptoms and the date of onset. Note the product, volume and date of the previous procedure, and whether toxin was used in the area. Photos of the gaze straight ahead, upward and downward help the ophthalmologist and protect the professional in case of a dispute.

How do you reduce the chance of it happening?

Choosing the patient well is half of prevention. The other half is conservatism: contained volumes, assessing the area in motion, attention to the relationship between neighboring procedures and early follow-up to review. When in doubt, the safest option is usually to postpone, treat gradually or refer for ophthalmology assessment first.

A simulation in an app, such as Harmy, does not show eyelid tension and does not replace the clinical exam. It is an illustrative simulation, not a promise of results: use the projection to align expectations, and leave the decision on indication to the in-person assessment.